Rituximab, ibrutinib clinical trials

Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia

This study compares two treatments for a rare blood cancer called Waldenström's macroglobulinaemia. We're looking for better, gentler options than current treatments, hoping to improve health and quality of life for patients.